Bayer Denies Claim Made By Plaintiff In A Related Yaz Case

Introduction

A New Jersey State Appeals Court found loopholes in the expert report of a woman who blamed Bayer AG's Yaz and Yasmin birth control pills for her gallbladder disease. The pharmaceutical giant denied the claim made by the plaintiff to restore the litigation.

The lawsuits concerning Yaz related pulmonary embolism were the first to go for state court trial, followed by gallbladder injury cases and the final round would include blood clot injuries.

By May 2014, Bayer settled more than 8,200 lawsuits over pulmonary embolisms, heart attack and deep vein thrombosis (DVT), spending nearly $1.7 billion. As of May 2018, 63 Yaz and Yasmin lawsuits are pending in the multidistrict litigation (MDL No. 2100; In Re: Yasmin and Yaz Marketing, Sales Practices and Products Liability Litigation), which was formed in 2009 and is presided by Judge David R. Herndon in the Southern District of Illinois.

Comments

Walgreens Settles Federal Opioid Case for $300 Million

Categories: Opioids

Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.

The U.S. Department of Justice announced on Monday…

Study: Opioid Use in Pregnancy May Shrink Newborn Brains

Categories: Opioids

New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…

Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting

Categories: Opioids

The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…

Bayer Denies Claim Made By Plaintiff In A Related Yaz Case